ATH alterity therapeutics limited

Ann: Investor presentation - Biotech Showcase, page-6

  1. 3,053 Posts.
    lightbulb Created with Sketch. 1128
    One detail in Stamler's presentaion: He tells that " MPTP mouse model •MPTP is a potent inhibitor of  complex 1 of the mitochondrial   electron transport chain " So  PBT434 is a mitochondrion drug also according Stamler because PBT434 works in this model. This is important also when thinking if niacin could help in different PD models. IMO very unlikely in MPTP model, it could perhaps compensate only NAD+ production but not if complex I does not work ( only my opinion here on the sofa). 
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.4¢
Change
-0.001(6.67%)
Mkt cap ! $128.9M
Open High Low Value Volume
1.3¢ 1.5¢ 1.3¢ $303.5K 22.27M

Buyers (Bids)

No. Vol. Price($)
10 17514645 1.4¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 5651369 18
View Market Depth
Last trade - 14.34pm 21/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.